ScreenerHero

CPTR Captor Capital Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · captorcapital.com
0.5700CAD-1.72%Mkt Cap: 1.45M $P/E: —

Captor Capital Corp. engages in the retail sale of cannabis products in the United States. It also engages in investment and merchant banking activities. The company was formerly known as NWT Uranium Corp. and changed it…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$57.82BUSD
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
TEVA
Teva Pharmaceutical Industries Limited
$45.64BUSDP/E 65.2
HLN
Haleon plc
$39.01BUSDP/E 18.1
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.7
UTHR
United Therapeutics Corporation
$23.23BUSDP/E 19.4
VTRS
Viatris Inc.
$20.15BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.79BUSDP/E 21.3
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.23BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.40BUSDP/E 28.4
KRK
Krka, d. d.
$8.63BUSDP/E 19.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.07BUSDP/E 41.4
ALKS
Alkermes plc
$6.99BUSDP/E 109.6
HIMS
Hims & Hers Health, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap1.45M USD
Enterprise Value-3.88M USD
Revenue (TTM)-3.68M USD
Gross Profit-3.68M USD
Net Income (TTM)-4.64M USD
Revenue/Share-1.45 CAD
Last Price0.5700 CAD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees78
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue1.06
P/S-0.39
P/B0.24
EPS (TTM)-1.62
EPS (Forward)—
52W Range
0.220073% of range0.7000
52W High0.7000 CAD
52W Low0.2200 CAD
Profitability
Gross Margin0.00%
Oper. Margin243.14%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-75.83%
ROA-65.60%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.44M USD
CapEx (TTM)—
FCF Margin75.51%
FCF Yield-191.74%
Net Debt-5.33M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.08
Current Ratio6.95
Quick Ratio6.95
Book Value/Sh2.37 CAD
Cash/Share2.29 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateJul 11, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.49M
Float—
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.2d
Short % Float0.02%
Short % Out.0.02%
Shares Short668
Short (prev mo.)147
Technical
SMA 500.3720 (+53.2%)
SMA 2000.2706 (+110.7%)
Beta0.66
S&P 52W Chg16.45%
Avg Vol (30d)1.34K
Avg Vol (10d)3.48K
Technical Indicators
RSI (14)75.6
MACD0.0964
MACD Signal0.0768
MACD Hist.+0.0196
BB Upper0.7579 CAD
BB Middle0.3835 CAD
BB Lower0.0091 CAD
BB Width195.26%
ATR (14)0.0341 CAD
Vol Ratio (20d)1.93x